At Enveda, we are tackling the toughest challenges in drug discovery, finding and developing new compounds from the expanse of the natural world. We’re doing it with metabolomics and machine learning that allow us to characterize those compounds in entirely new ways. All of us at Enveda share a commitment to the health of those who will use the drugs we’re developing today.
Subscribe to follow our progress.
Subscribe_logo.svg){kind=logo}
11/11/2022
The core problem in natural product drug discovery: finding needles in nature’s haystack.
Read more10/19/2022
Protein degradation, whether as a PROTAC (proteolysis targeting chimera) or a molecular glue, is an emerging new modality of therapeutic action...
Read more
06/22/2021
Lux Capital has led a $51 million venture-capital financing in Enveda Biosciences Inc., a biotechnology startup led by an entrepreneur who previously helped...
Read moreTRANSFORMing natural product drug discovery: machine learning for high-fidelity chemical property prediction from metabolomics data
The core problem in natural product drug discovery: finding needles in nature’s haystack.
Read moreNatural Products in Protein Degradation: Past, Present, and Future
Protein degradation, whether as a PROTAC (proteolysis targeting chimera) or a molecular glue, is an emerging new modality of therapeutic action...
Read moreEnveda Biosciences to Open Advanced Drug Discovery and Development Center in Boulder, Colo.; Lead Optimization Laboratory in Hyderabad, Telangana, India
Enveda Biosciences to Open Advanced Drug Discovery and Development Center in Boulder, Colo.; Lead Optimization Laboratory in Hyderabad, Telangana, India...
Read moreEnveda Biosciences Adds Drug Development Leaders to Scale Efforts and Accelerate Progress
New team members deepen Enveda’s global drug development expertise as its therapeutics pipeline expands and advances...
Read moreA Recursion veteran is mapping plant life to chart a course to new therapies — and investors like what they see
One of the earliest employees at AI biotech Recursion Pharmaceuticals is leading a new company, and he’s just closed a hefty Series A to get things moving...
Read moreLux Capital Leads $51 Million Financing in Biotech Startup Enveda - Company searches for compounds from nature to develop medications
Lux Capital has led a $51 million venture-capital financing in Enveda Biosciences Inc., a biotechnology startup led by an entrepreneur who previously helped...
Read moreEnveda Biosciences Closes $51M Series A Financing Led by Lux Capital
Enveda Biosciences, a leading biotechnology company harnessing the power of nature’s chemistry to develop next-gen small molecule therapeutics, today announc...
Read moreExploiting the Therapeutic Potential of Plants
Technology Networks recently interviewed Viswa Colluru, founder and CEO of Enveda Biosciences, to find out how the company is “harnessing the complexity of...
Read moreExclusive: Enveda Biosciences Announces $4.9M Seed To Create Medicinal Plant Database
Enveda Bioscienes has raised a seed round of $4.9 million to build what it touts to be the “world’s largest database of anthropological, chemical and biologi...
Read moreEnveda Biosciences Systematically Harnesses Untapped Potential of Nature’s Chemistry to Develop Next-Gen Therapeutics
Enveda Biosciences today announced its seed round of funding in the amount of $4.9 million led by True Ventures, with participation from Wireframe Ventures...
Read moreWhy we invested in Enveda
In the Spring of 2018, one of our LPs based in Salt Lake City introduced me to a founder named Dan Wee from the vibrant bioscience community there...
Read moreBioactivity-Based Molecular Networking for the Discovery of Drug Leads in Natural Product Bioassay-Guided Fractionation
It is a common problem in natural product therapeutic lead discovery programs that despite good bioassay results in the initial extract, the active compound...
Read moreMass spectrometry searches using MASST
Introduced in 1990, a tool for discovering related protein or gene sequences named Basic Local Alignment Search Tool (BLAST) enabled researchers to query...
Read moreGlobal chemical effects of the microbiome include new bile-acid conjugations
A mosaic of cross-phylum chemical interactions occurs between all metazoans and their microbiomes...
Read moreCelebrating the departure of an outstanding employee
A few weeks ago, Viswa Colluru, a Senior Product Manager at Recursion, scheduled time with me to share that he would be leaving Recursion...
Read more
Machine Learning will Revolutionize Metabolomics
Metabolomics is a rapidly emerging field that seeks to measure the landscape of metabolites, or organic small molecules, in liv...
Read moreFulfilling the Promise of Natural Products with Technology: Discovering the Next Generation of Small Molecules
In twenty years of Big Pharma experience, I have seen both the promise of small-molecule Drug Discovery (helping take four mole...
Read moreDrug Discovery Productivity at Enveda —Biotech Innovation with Big Pharma Efficiency
Once the initial project goals are defined, biologists build assays that can reproducibly evaluate compounds (agonists, antagon...
Read moreArtemisinins, Malaria, and The Quest to Systematize Collaboration between Nature and Scientists (Cures and Nobel Prizes)
Mother Nature is, by far, the most accomplished drug discovery researcher in the history of the world, in spite of the fact..
Read more
